FDA Requires Review of Personal Genomics Kits

June 14, 2010 | The FDA sent letters to 23andMe, Navigenics, deCODE Genetics, Illumina, and Knome on Friday explaining that the companies' consumer genomics kits should be reviewed under the same process used for medical devices. The FDA will decide after review if the products can remain on the market. San Francisco Chronicle